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Regular physical activity using large muscle groups, suchas walking, running, or swimming, produces cardiovas-
cular adaptations that increase exercise capacity, endurance,
and skeletal muscle strength. Habitual physical activity also
prevents the development of coronary artery disease (CAD)
and reduces symptoms in patients with established cardiovas-
cular disease. There is also evidence that exercise reduces the
risk of other chronic diseases, including type 2 diabetes,1
osteoporosis,2 obesity,3 depression,4 and cancer of the breast5
and colon.6 This American Heart Association (AHA) Scien-
tific Statement for health professionals summarizes the evi-
dence for the benefits of physical activity in the prevention
and treatment of cardiovascular disease, provides suggestions
to healthcare professionals for implementing physical activity
programs for their patients, and identifies areas for future
investigation. This statement focuses on aerobic physical
activity and does not directly evaluate resistance exercises,
such as weight lifting, because most of the research linking
physical activity and cardiovascular disease has evaluated
aerobic activity. Whenever possible, the writing group has
cited summary articles or meta-analyses to support conclu-
sions and recommendations. This evidence supports the
recommendation from the Centers for Disease Control and
Prevention (CDC) and the American College of Sports
Medicine (ACSM) that individuals should engage in 30
minutes or more of moderate-intensity physical activity on
most (preferably all) days of the week.7
Definition of Terms
Physical activity is defined as any bodily movement produced
by skeletal muscles that results in energy expenditure beyond
resting expenditure. Exercise is a subset of physical activity
that is planned, structured, repetitive, and purposeful in the
sense that improvement or maintenance of physical fitness is
the objective. Physical fitness includes cardiorespiratory fit-
ness, muscle strength, body composition, and flexibility,
comprising a set of attributes that people have or achieve that
relates to the ability to perform physical activity. When
defining the amount of physical activity or exercise, an
important interrelationship exists between the total dose of
activity and the intensity at which the activity is performed.
Dose refers to the total amount of energy expended in
physical activity, whereas intensity reflects the rate of energy
expenditure during such activity.7 Intensity can be defined in
absolute or relative terms. Absolute intensity reflects the rate
of energy expenditure during exercise and is usually ex-
pressed in metabolic equivalents or METs, where 1 MET
equals the resting metabolic rate of 3.5 mL O2 · kg1 ·
min1. Relative intensity refers to the percent of aerobic
power utilized during exercise and is expressed as percent of
maximal heart rate or percent of V˙ O2max. Moderate-intensity
activities are those performed at a relative intensity of 40% to
60% of V˙ O2max (or absolute intensity of 4 to 6 METs).
Vigorous-intensity activities are those performed at a relative
intensity of 60% of V˙ O2max (or absolute intensity of 6
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METs). For example, brisk walking at 4.8 km · h1 (3 miles
· h1) has an absolute intensity of4 METs. In relative terms,
this intensity is considered light for a 20-year-old healthy
person but represents a vigorous intensity for an 80-year-old
person.8
Prevention of Atherosclerotic Vascular Disease
During the past half-century, prospective epidemiological
studies of occupational and leisure-time physical activity
have consistently documented a reduced incidence of CAD
events in the more physically active9 and fit10 subjects. More
recent studies have provided similar data by using measures
of exercise capacity such as treadmill performance as an
indicator of habitual physical activity. The data satisfy the
criteria required to infer a causal relationship from epidemi-
ological evidence.11,12 The results are strong, with the most
physically active subjects generally demonstrating CAD rates
half those of the most sedentary group. The data demonstrate
a graded relationship of decreasing CAD rates with increas-
ing levels of activity. Multiple studies were prospective and
thereby demonstrate appropriate sequencing because the
lower physical activity levels preceded the development of
CAD rather than resulted from the disease itself. The results
are consistent with all published studies documenting lower
CAD rates in the more active subjects, although the relation-
ship did not reach statistical significance in some individual
reports. In many studies, the lower frequency of CAD was
independent of other known atherosclerotic risk factors. The
results are also plausible and coherent with evidence demon-
strating beneficial effects of exercise on atherosclerotic risk
factors, myocardial function, coronary artery size and vaso-
dilatory capacity, vascular tone, and vulnerability to ventric-
ular fibrillation. Available data do not provide clear evidence
that withdrawal of physical activity increases CAD risk,
although results from the Harvard Alumni Study suggest that
college athletic activity is not protective in later years without
lifelong physical activity.13 Studies using the best designs and
measurement instruments tend to show the strongest relation-
ships between physical activity and decreased CAD events,
probably because superior assessment techniques limit inac-
curacies in categorizing physical activity levels.10 For exam-
ple, studies on cardiorespiratory fitness, measured as tread-
mill performance times, and CAD show stronger associations
than are seen in activity studies, probably because of the
better classification by objective measures of fitness in
comparison to the relatively imprecise assessments of self-
reported physical activity.10 These epidemiological studies,
combined with studies providing biological plausibility, pro-
vide conclusive evidence that physical activity reduces the
incidence of CAD.
Reduction of Atherosclerotic Risk Factors
Physical activity both prevents and helps treat many estab-
lished atherosclerotic risk factors, including elevated blood
pressure, insulin resistance and glucose intolerance, elevated
triglyceride concentrations, low high-density lipoprotein cho-
lesterol (HDL-C) concentrations, and obesity. Exercise in
combination with weight reduction can decrease low-density
lipoprotein cholesterol (LDL-C) concentrations and limit the
reduction in HDL-C that often occurs with a reduction in
dietary saturated fat.14
The magnitude of the exercise effect is influenced by
characteristics of the exercise intervention, individual varia-
tion, and whether exercise produces concomitant reductions
in body weight. The effect on atherosclerotic risk factors can
be large in some individuals and obviate the need for other
interventions. In general, the effect of exercise on atheroscle-
rotic risk factors is substantially less than that achieved by
pharmacological therapies, although the exercise effect can
be significantly magnified by other lifestyle changes such as
changes in dietary composition and weight loss.
A meta-analysis of 52 exercise training trials of 12
weeks’ duration including 4700 subjects demonstrated an
average increase in HDL-C levels of 4.6% and reductions in
triglyceride and LDL-C concentrations of 3.7% and 5.0%,
respectively.15,16 The largest and most carefully controlled
exercise trial, the HEalth, RIsk factors, exercise Training,
And GEnetics (HERITAGE) study, included 675 normolipi-
demic subjects who participated in 5 months of exercise
training.17 HDL-C increased 1.1 mg/dL (3%) among the 299
men studied, whereas triglycerides and LDL-C decreased 5.9
and 0.9 mg/dL or 2.7% and 0.8%, respectively. HDL-C
among the 376 women increased 1.4 mg/dL (3%), and
triglycerides and LDL-C decreased 0.6 and 4.4 mg/dL or
0.6% and 4%, respectively. Greater increases in HDL-C may
occur in individuals with baseline hypertriglyceridemia,18 but
few studies have addressed the effect of exercise in subjects
with lipid disorders.
At least 44 randomized controlled trials including 2674
participants have studied the effect of exercise training on
resting blood pressure.19 The average reduction in systolic
and diastolic blood pressure was 3.4 and 2.4 mm Hg, respec-
tively. Baseline blood pressure was an important determinant
of the exercise effect. Average systolic and diastolic blood
pressures decreased 2.6 and 1.8 mm Hg in normotensive
subjects and 7.4 and 5.8 mm Hg in hypertensive subjects,
respectively, suggesting that exercise may serve as the only
therapy required in some mildly hypertensive subjects. There
was no relationship between the weekly training frequency,
time per session, or intensity of exercise training and the
magnitude of the blood pressure reduction, which suggests
that the dose-response curve for exercise and blood pressure
is flat.
Physical activity also reduces insulin resistance and glu-
cose intolerance, postprandial hyperglycemia, and possibly
hepatic glucose output.20 A review of 9 trials examining the
effect of exercise training in 337 patients with type II diabetes
reported an average reduction of hemoglobin (Hgb) A1c of
0.5% to 1%.20 These findings may underestimate the absolute
decrease in Hgb A1C because of concomitant reductions in
diabetic medications. The Diabetes Prevention Program dem-
onstrated the powerful effect that physical activity and weight
loss can exert in preventing the onset of type II diabetes in
individuals at high risk for this disease.1 Compared with usual
care, there was a 58% reduction in the onset of type II
diabetes over 2.8 years among individuals randomized to a
lifestyle intervention that produced an average 4-kg decrease
in body weight and an 8-MET-h/wk increase in physical
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activity. The latter corresponds to an additional 593 kcal of
energy expenditure weekly or 6 miles of walking for a
70-kg individual. The lifestyle intervention was also signifi-
cantly more powerful than metformin (850 mg BID), which
reduced the onset of type II diabetes by 31%.
Physical activity is also an important adjunct to diet for
achieving and maintaining weight loss. The National Weight
Control Registry enrolled 3000 individuals who lost10% of
their body weight and maintained this weight loss for at least
1 year.3 The average weight loss of 30 kg was maintained for
an average of 5.5 years. Eighty-one percent of the registrants
reported increased physical activity. Women and men, re-
spectively, reported expending 2445 and 3298 kcal weekly in
such activities as walking, cycling, weight lifting, aerobics,
running, and stair climbing.
At least 8 studies have examined the adjunctive effect of
exercise on smoking cessation, but most trials were small and
the results not subjected to meta-analysis.21 One larger trial
randomly assigned 281 healthy women to a 12-week behavior
modification program and thrice-weekly sessions of super-
vised vigorous exercise or to an identical behavioral program
with thrice-weekly health education sessions.22 Of the exer-
cisers, 19.4% achieved at least 2 months of continuous
abstinence at the end of the 12-week intervention, compared
with 10.2% of the controls. At 12-month follow-up, 11.9% of
the exercisers and 5.4% of the controls remained continu-
ously abstinent. Such results are preliminary, but they suggest
that physical activity facilitates long-term smoking cessation
by increasing the initial quit rate.
Some of the effect of physical activity on cardiovascular
risk factors is an acute effect of recent exercise and is not
dependent on prolonged exercise training or improvement in
fitness.20 Serum triglycerides are reduced by vigorous exer-
cise for up to 72 hours.20 HDL-C is also transiently increased
by exercise.20 Vigorous exercise also acutely reduces systolic
blood pressure, and this effect may persist for up to 12
hours.20 Exercise also has favorable acute effects on glucose
homeostasis.20 These acute effects provide additional support
for the recommendations from the CDC and the ACSM that
adults should participate in moderate-intensity physical ac-
tivity on most, if not all, days of the week.7
Treatment for Patients With Diagnosed CAD
Several meta-analyses have concluded that comprehensive,
exercise-based cardiac rehabilitation reduces mortality rates
in patients after myocardial infarction.23,24 The most recent
and comprehensive meta-analysis identified 51 randomized
controlled trials of exercise-based cardiac rehabilitation.25 All
studies were published before January 1, 1999, and included
8440 patients who were primarily middle-aged, low-risk men.
Patients were included if they had sustained a myocardial
infarction, had undergone coronary artery bypass grafting or
percutaneous transluminal coronary angioplasty, had angina
pectoris, or had CAD identified by angiography. Supervised
exercise training in these programs was generally of 2 to 6
months’ duration followed by unsupervised exercise.23,24 The
mean follow-up was 2.4 years.25 Results were analyzed
according to whether the cardiac rehabilitation program
consisted of exercise only or also included psychosocial
and/or educational interventions.25 Total mortality was re-
duced 27% (P0.05) with the exercise-only intervention and
13% (PNS) with comprehensive rehabilitation (Table).
Cardiac mortality was reduced 31% (P0.05) and 26%
(P0.05) for the exercise-only and comprehensive programs,
respectively. Neither the exercise-only program nor the com-
prehensive intervention significantly reduced the rate of
nonfatal myocardial infarction. Additionally, rates of sudden
cardiac death were not reduced, although only 4 exercise-only
and 14 comprehensive rehabilitation trials analyzed this
outcome. Similarly, only 5 exercise-only trials and 10 com-
prehensive trials examined the rate of coronary artery bypass
grafting.
This review25 adds 4000 patients to the prior, widely
cited meta-analyses of cardiac rehabilitation23,24 and confirms
that exercise-based cardiac rehabilitation reduces cardiac
mortality but does not reduce the risk of recurrent myocardial
infarction. In contrast to the prior analyses, however, these
recent results suggest that the exercise component is a critical
aspect of the rehabilitation process. The reduction in death
without a reduction in nonfatal reinfarction raises the possi-
bility that exercise training enhanced electrical stability and
reduced ventricular fibrillation26 or reduced myocardial dam-
age directly or via such factors as ischemic preconditioning.27
Many of the studies in this meta-analysis preceded most of
the present treatments for CAD patients, including wide-
spread use of acute thrombolytic therapy, primary angio-
plasty, aggressive revascularization, -adrenergic blockers,
aggressive lipid management, and angiotensin-converting
Effect of Exercise-Based Cardiac Rehabilitation on Cardiac Events
Outcome
Mean
Difference
95%
CI
Statistically
Significant?
Exercise-only intervention
Total mortality 27% 2% to40% Yes
Cardiac mortality 31% 6% to49% Yes
Nonfatal myocardial infarction 4% 31% to35% No
Comprehensive rehabilitation
Total mortality 13% 29% to5% No
Cardiac mortality 26% 4% to43% Yes
Nonfatal myocardial infarction 12% 30% to12% No
CI indicates confidence intervals. CIs not including zero are statistically significant.
Data are derived from Jolliffe et al.25
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enzyme inhibitors. The smaller effect of comprehensive
cardiac rehabilitation in this review may also reflect the
absence of more powerful interventions to lower cardiovas-
cular risk, such as newer lipid-lowering agents. Thus, it is not
clear that exercise therapy after myocardial infarction would
have as great an impact on mortality rates in the present era
of cardiovascular disease management. Similarly, the effects
of medical treatment may be overestimated in medical inter-
vention trials not involving exercise.
Exercise training is also useful for patients with angina
pectoris who are not candidates for revascularization therapy
because of disease not amenable to intervention, angiographi-
cally noncritical stenoses, or patient preference. Early studies
demonstrated that the symptomatic improvement in exercise
tolerance after exercise training was due primarily to a
reduction in the heart rate and systolic blood pressure or
rate-pressure product (RPP) at submaximal workloads with
no change in the RPP at the onset of angina.28 Some
subsequent reports also demonstrated an increase in the RPP
at the onset of angina as well as a reduction in the ischemic
response measured as angina, ST-segment depression,29 or
nuclear and positron-emission tomography scanning perfu-
sion defects30,31 at a given RPP, which suggests that exercise
training improved myocardial oxygen delivery. In one study,
the increase in RPP at the onset of angina occurred only
during exercise,32 whereas the RPP at the onset of angina with
ventricular pacing was unchanged. These findings suggest
that exercise training altered the coronary vasomotor re-
sponse to exercise.32 This hypothesis is supported by recent
angiographic studies documenting that exercise training re-
duces the abnormal vasoconstrictive response to acetylcho-
line in patients with CAD and documented endothelial
dysfunction.33
The aforementioned studies support the use of physical
activity to improve exercise capacity after coronary revascu-
larization procedures, including coronary bypass surgery and
percutaneous interventions. No large studies have directly
addressed the utility of exercise in this group, although there
are encouraging data. The Exercise Training Intervention
after Coronary Angioplasty (ETICA) trial34 randomized 118
consecutive patients to 6 months of exercise training or
control. Angiographic restenosis was not affected by exercise
training, but trained patients demonstrated significant in-
creases in peak V˙ O2 (26%) and quality-of-life parameters
(27%). Furthermore, during 337 months of follow-up, the
exercise-trained patients had fewer cardiac events (11.9%
versus 32.2%) and hospital readmissions (18.6% versus 46%)
than subjects assigned to usual care. Residual coronary
stenosis and recurrent cardiac events were reduced by 30%
and 29%, respectively, in the trained subjects.
Treatment for Patients With Heart Failure
Activity restriction was recommended for heart failure (HF)
patients until the late 1970s and 1980s, when it was recog-
nized that exercise capacity in patients with left ventricular
dysfunction could not be predicted by such parameters as
intracardiac filling pressures and left ventricular ejection
fraction. Numerous trials have demonstrated that both exer-
cise testing and training of patients with HF appear to be safe.
A detailed discussion of exercise and HF is presented in the
AHA Statement on Exercise and Heart Failure.35 Exercise
training benefits HF in several ways. The mean increase in
peak V˙ O2 in 15 randomized controlled trials of exercise
training that included 426 HF patients was 20.5%. The
frequency, duration, and intensity varied among the trials, but
all showed an increase in the average peak V˙ O2 between 12%
and 31%.35 In addition to improving exercise capacity,
exercise training in HF patients has been shown to improve
cardiac output at maximal workloads,36 improve mitochon-
drial size and density,37 increase skeletal muscle oxidative
enzymes, reduce endothelial dysfunction,38 and decrease
circulating catecholamines.39 Exercise training has also been
shown to improve quality of life in both men and women with
moderate, chronic HF.40 Whether these physiological adap-
tations will ultimately reduce mortality and morbidity is yet
to be determined by a large prospective trial, although there is
at least one small trial which showed a reduction in hospital-
izations and improved 1-year survival.41 A prospective large
randomized trial, Heart Failure—A Controlled Trial Investi-
gating Outcomes of exercise traiNing (HF-ACTION), has
been funded by the National Institutes of Health. This trial
proposes to randomize HF patients to a formal exercise-
training program or usual care with the primary end points of
all-cause mortality and all-cause hospitalizations.
Treatment for Patients With Peripheral Arterial
Disease and Claudication
Progressive physical activity is an effective treatment for
improving walking distance in patients with peripheral arte-
rial disease and exercise-induced claudication. Supervised
exercise may serve as a primary therapy for many individuals
with claudication if such a program is available and if
claudication is the primary functional limitation. A meta-
analysis of 21 exercise programs for patients with claudica-
tion demonstrated that, after exercise training, average walk-
ing distance to pain onset increased 179% or 225 m, and
average distance to maximal tolerated pain increased 122% or
397 m.42 Although there are few direct comparisons of
therapeutic exercise programs versus pharmacological or
surgical interventions, these increases in walking distance are
greater than those reported for the most widely used agents
for claudication, pentoxyphyline and cilostazol. The greatest
improvement with exercise training for claudication occurred
with training to maximal tolerated pain, when training lasted
at least 6 months, and when walking was the primary mode of
exercise.42 A review of randomized controlled trials suggests
that the evidence favoring exercise training outweighs that for
peripheral angioplasty in improving exercise tolerance in
claudication patients.43 In contrast, a direct comparison of
invasive treatment and supervised exercise training found
improvement at 1 year only in the invasively treated pa-
tients,44 so the issue remains controversial. In addition, no
trials have examined the effect of exercise training on the
need for revascularization or on subsequent cardiovascular
events or mortality in patients with claudication.
Exercise Training for Older Patients With CAD
Older patients constitute a high percentage of those with
diagnosed CAD and are at high risk for disability after a
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coronary event. Studies of exercise rehabilitation in patients
65 years of age have evaluated outcomes in the elderly
patients with coronary disease. Older patients with CAD have
exercise trainability comparable to that of younger patients
participating in similar exercise rehabilitation, with elderly
male and female patients showing comparable improve-
ment.45–47 However, referral to and participation in exercise
rehabilitation is less frequent for older patients, especially for
older women.48 No significant complications or adverse
outcomes of exercise training in older patients have been
described in any study. Consequently, older patients of both
genders should be strongly encouraged to participate in
exercise-based cardiac rehabilitation.
Whether exercise training is associated with a reduction of
morbidity or mortality in the elderly CAD patient is contro-
versial, although in the British Regional Heart Study, men
with CAD and a mean age of 63 years who engaged in
light-to-moderate physical activity had a significantly lower
all-cause mortality over the 5-year follow-up than did their
sedentary counterparts.49
Risks of Physical Activity
Physical activity and exercise training have risks that must be
considered when recommending regular physical activity for
the general population and for individuals with cardiovascu-
lar disease. Fortunately, several strategies are recognized as
effective at reducing risk when recommending physical
activity. Overall, available information suggests that physical
activity in the range recommended by recent public health
guidelines, such as the CDC/ACSM guideline,7 has quite an
acceptable risk-to-benefit ratio. The most common risk of
physical activity in adults is musculoskeletal injury.50,51 The
incidence of injury can be as high as 55% in 8 weeks among
women undergoing US Army basic training.52 In contrast,
injuries are rare in research studies of supervised exercise
training among older adults when individuals at high risk of
injury are excluded.53 In a cohort study of community adults
aged 20 to 85 years with above-average activity levels,25%
reported a musculoskeletal injury over 1 year,50 and one third
of injured adults stopped exercising. Several factors affecting
injury risk are modifiable and offer opportunities for risk
management. Risk of injury increases with obesity,51 volume
of exercise,50 and participation in vigorous exercise such as
competitive sports,54 whereas higher fitness,50 supervision,
stretching exercises, protective equipment such as bike hel-
mets, and well-designed environments protect against injury.
The general principle that the volume of physical activity
should be increased gradually over time is widely regarded as
critical for reducing injury risk.7 Walking, the most popular
activity and the standard example of a moderate-intensity
activity, is a low-risk activity. One study reported that
increasing the duration of walking did not result in any
increase in injury risk.50 In some situations, regular physical
activity actually reduces injury risk, as indicated by a recent
consensus statement that physical activity is recommended to
reduce the risk of fall injuries in older adults.55
Vigorous physical activity acutely increases the risk of
sudden cardiac death56,57 and myocardial infarction58,59
among individuals with both diagnosed and occult heart
disease. A variety of congenital and acquired conditions such
as hypertrophic cardiomyopathy, coronary artery anomalies,
aortic stenosis, and cardiomyopathies are associated with
sudden death during vigorous activity in children and young
adults.60,61 Recommendations for athletic screening and par-
ticipation for these conditions have been presented in the
AHA Statement on Cardiovascular Preparticipation Screen-
ing of Competitive Athletes.62 The incidence of sudden death
during exercise is not well defined in this age group. Among
high school and college athletes, an estimated 1 death per
year occurs during or within an hour after athletic activity for
every 133 333 male and 769 230 female participants.60 Ath-
erosclerotic CAD is the overwhelming cause of exercise-
related deaths in adults.56,57 The incidence has been estimated
to be 1 exertion-related death per year for every 15 00056 to
18 00057 ostensibly healthy men. These incidence rates are
based on only 1056 and 957 exercise-related deaths, which
gives these figures wide confidence limits. A preliminary
report from a 3-million-member national fitness facility noted
61 male and 10 female deaths over 2 years and calculated
incidence rate of 1 death per 82 000 members per year or 2.6
million workouts.63 Although the absolute incidence of sud-
den death associated with exercise is quite low, exercise does
acutely increase the rate of sudden death compared with more
leisurely activities.56,57 Exercise also transiently increases the
risk of acute myocardial infarction.58,59 Approximately 5% to
10% of myocardial infarctions are associated with vigorous
physical activity. The relative risk of both exercise-related
myocardial infarction and sudden death is greatest in individ-
uals who are the least physically active and who were
performing unaccustomed vigorous physical activity.57–59
Sedentary adults should avoid isolated bouts of unaccus-
tomed vigorous physical activity and should follow the
standard recommendation to increase physical activity levels
gradually over time. The possible value of this strategy is
supported by the observation that the risk of exercise-related
cardiac events is greatest in the least active individuals.57,59
Because atherosclerotic CAD is the most frequent cause of
exercise-related events, the incidence of such events is higher
among patients with known atherosclerotic coronary disease.
Among participants in cardiac rehabilitation programs, the
average incidence of cardiac arrest, nonfatal myocardial
infarction, and death is 1 for every 117 000, 220 000, and
750 000 patient-hours of participation,64 respectively. The
low ratio of cardiac arrest to death is due to the availability of
acute medical care.
Recommendations
The evidence summarized above and more extensively pre-
sented in the 1996 Surgeon General’s Report65 attests to the
value of exercise and physical activity in reducing the
incidence of coronary heart disease. Indeed, the original AHA
Statement on Exercise in 199266 was among the first docu-
ments to conclude that physical inactivity is a major CAD
risk factor. Because atherosclerotic vascular disease remains
the major cause of death in many countries, it is important
that healthcare providers support the implementation and
maintenance of exercise programs for their patients across the
lifespan.
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Health professionals should personally engage in an active
lifestyle to familiarize themselves with the issues involved in
maintaining lifelong physical activity and to set a positive
example for patients and the public. This may increase the
likelihood that healthcare providers will recommend physical
activity to their patients. Healthcare providers should use
their influence as parents and community members to encour-
age schools to provide physical education programs that teach
the importance of, and the skills necessary for, developing
and maintaining physically active lifestyles. There is growing
recognition of the contribution of social support and the value
of integrating behavioral changes into daily routines to
sustain improvements in physical activity levels. For this
reason, healthcare providers should advocate changes in
organizational practices within work sites and civic and
recreational settings that encourage active living. Health
professionals should also encourage their communities to
make facilities for physical activity available to the public
and to engineer environments conducive to safe physical
activity. Such environmental engineering efforts should allow
purposeful physical activities, such as walking to work and
climbing stairs, to be used in lieu of labor-saving devices.
Health professionals should support public health efforts that
encourage these active lifestyles.
The importance of physical activity for health and the use
of exercise training in managing selected disease states
should be incorporated into the education of physicians and
other medical professionals. A physical activity history is an
important component of the health history, and healthcare
providers should include the patient’s habitual physical ac-
tivity as part of the medical record. Healthcare providers
should identify for patients the importance of physical activ-
ity as primary or adjunctive therapy for such medical condi-
tions as hypertension, hypertriglyceridemia, glucose intoler-
ance, and obesity.
Health professionals should prescribe physical activity
programs commensurate with those recommended by the
CDC and the ACSM, ie, 30 minutes or more of moderate-
intensity physical activity such as brisk walking on most, and
preferably all, days of the week.7 Patients should be encour-
aged to engage in a variety of physical activities and to
progressively increase their activity as tolerated. Detailed
guidelines for prescribing exercise in patients with and
without cardiovascular disease are provided in the AHA
Exercise Standards for Testing and Training.8 Recommenda-
tions are also available for the incorporation of resistance and
flexibility exercise training.67 Healthcare professionals
should provide an exercise prescription to patients and should
familiarize themselves with behavioral change material avail-
able from the Provider-Based Assessment and Counseling for
Exercise Program (PACE)68 and the Activity Counseling
Trial (ACT).69
It is not necessary that all individuals beginning a
moderate-intensity and moderately progressive exercise pro-
gram undergo an exercise stress test, although this issue
remains controversial. A Consensus Group from the AHA
and the American College of Cardiology70 considered routine
exercise stress testing before the initiation of a vigorous
exercise program in healthy men 45 and women 55 years
of age as a Class IIb Recommendation—ie, a condition in
which the usefulness and efficacy is not well established.
Selected exercise testing should be performed at the discre-
tion of the physician before vigorous exercise in patients with
known cardiovascular problems.
Healthcare providers caring for patients with diagnosed
cardiovascular disease should support the development of
exercise programs to manage these patients and make appro-
priate referrals for treatment. There are also effective strate-
gies to promote active lifestyles for whole communities that
complement those designed for individuals. The Task Force
on Community Preventive Services has completed an
evidence-based review of these community strategies.71 The 6
strategies deemed effective were: (1) large-scale, intense,
highly visible, community-wide campaigns; (2) point-of-
decision prompts that encourage people to use the stairs
instead of elevators or escalators; (3) physical education
programs in schools; (4) social support programs (such as
buddy systems and walking groups); (5) individually adapted
behavior change programs; and (6) enhanced access to places
for physical activity. For example, 12 studies have studied
increasing access to places for physical activity, with a
median effect size of a 26% increase in persons exercising at
least 3 days per week.
Areas for Future Investigation
Although there is sufficient evidence to encourage increased
physical activity for the public and most patient groups,
multiple aspects of physical activity and health warrant
additional investigation. Foremost is research into behavioral
strategies and techniques to increase physical activity levels
among children and adolescents and to maintain increased
activity over their lifespans. Similar information on factors
influencing the adoption and maintenance of physical activity
is required for adults. In particular, there is a need to focus on
physical activity promotion efforts via organizational (eg,
work sites and communities) and legislative policy changes,
rather than just on the individual level. Additionally, the
message that incremental change in physical activity behavior
is important has to be emphasized so that patients do not see
physical activity participation as an all-or-none behavior, like
cigarette smoking. Much has been learned in the past decade
about how to use behavioral interventions to help sedentary
adults become more active in individual and small-group
settings. There is a need to evaluate the efficacy of dissemi-
nating these interventions with modern technology, such as
the Internet. Additional physiological and basic research is
necessary to provide the scientific rationale supporting the
importance of physical activity. Such research should address
the mechanisms by which exercise reduces CAD risk as well
as explore other medical conditions effectively managed by
exercise training. The contribution of physical inactivity to
the development of the present obesity epidemic warrants
additional investigation, as does the role of physical activity
in the treatment of obesity. It is important to develop
information on the minimal and optimal amounts of exercise
and physical activity required to produce specific beneficial
outcomes and to understand individual differences that may
augment or impede the beneficial effects of physical training.
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More attention also needs to be given to assessing the health
benefits from physical activity when intensity is measured
relative to the individual’s fitness and not as an absolute
value. Additional studies are needed on the value of physical
activity programs superimposed on contemporary therapy for
CAD patients because most data forming our knowledge base
were obtained more than a decade ago when CAD mortality
rates were substantially higher than at present. Additional
studies are also needed on the risks of exercise because the
benefits of exercise for patients with diagnosed or occult
CAD can be maximized only if the risks are as low as
possible. Finally, cost-effectiveness studies are needed to
evaluate the role of physical activity relative to other inter-
ventions on healthcare costs.
Summary of Key Points
(1) Physical activity and exercise training have important
roles in:
A. Preventing atherosclerotic CAD;
B. Managing selected CAD risk factors, including ele-
vated triglyceride levels, low HDL-C, hypertension,
glucose intolerance, hypertension, obesity, and possibly
cigarette use;
C. Treating patients with CAD, HF, and claudication.
(2) Healthcare professionals should:
A. Engage in an active lifestyle;
B. Encourage schools to teach skills required for physi-
cally active lifestyles and communities to develop
programs and facilities conducive to physical activity;
C. Be educated about exercise as a therapeutic modality
and the importance of lifelong physical activity in their
patients;
D. Routinely prescribe exercise and increased physical
activity to their patients in accordance with recommen-
dations provided by the CDC/ACSM7 and the AHA8;
E. Perform exercise testing before vigorous exercise in
selected patients with cardiovascular disease and other
patients with symptoms or those at high risk.
(3) Additional research should:
A. Address behavioral strategies to increase and maintain
physical activity over the lifespan;
B. Increase the scientific rationale supporting the impor-
tance of physical activity by examining the amount of
exercise required to alter CAD risk, the effect of
exercise on morbidity and mortality, and its
cost-effectiveness.
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